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To study the effect of puberty on the relationship between serum 25-hydroxyvitamin D (25(OH)D) and parameters of insulin
kinetics in obese Asian-Indian children. Material and Methods. The study population included 62 obese Asian-Indian children
and adolescents in the age group of 6–17 years. Blood glucose, serum insulin, and serum 25(OH)D were measured. Total body
fat was measured by dual energy X-ray absorptiometry. Indices of insulin resistance (HOMA-IR, AUC for insulin) and sensitivity
(WBISI) were calculated after oral glucose tolerance test. Result. A total of 62 subjects (35 boys; mean age = 13.0 ± 3 years; BMI =
29.3 ± 4.8 kg/sqM; 19 subjects in Tanner stage 1, 11 in stage 2, 6 in stage 3, 3 in stage 4, and 23 subjects in Tanner stage 5) were
studied. All study subjects were vitamin D deficient with a mean serum 25(OH)D of 8.5 ± 4.2 ng/mL. No significant relationship
was observed between serum 25(OH)D and parameters of insulin kinetics in prepubertal children. However, a significant inverse
correlation was seen between serum 25(OH)D and HOMAIR (r = −0.41, P = 0.03) in postpubertal subjects. Conclusion. The
relationship between vitamin D status and parameters of insulin kinetics are affected by puberty.
1. Introduction
Vitamin D deficiency was once thought to exclusively affect
bone metabolism, but now there is ample evidence of its role
in many other conditions including metabolic syndrome,
autoimmune diseases, and cancer [1]. Vitamin D receptors
are recognized to be in numerous extraskeletal tissues,
such as pancreas and muscle [2]. A systematic review by
Pittas and colleagues [3] reported that vitamin D may
have a beneficial effect on the action of insulin, either
directly or indirectly. Several observational studies in adults,
including the Framingham Heart Study [4], have reported
an inverse association between vitamin D status and insulin
resistance. However, data from children and adolescents
do not consistently report this inverse relationship [5–10].
Even in studies reporting this association in adolescents and
children, the strength of association has been found to be
very modest [6]. Further, none of the studies in adolescents
have studied the effect of puberty on this association. A fall
in insulin sensitivity with compensatory increase in insulin
secretion has been reported in puberty [11, 12].
High prevalence of cardiometabolic risk factors, includ-
ing insulin resistance (64.8% of normal weight children had
at least one cardiometabolic abnormality), even in healthy
young children of normal weight, has been reported in
Indian children and adolescents [13]. South-Asian adoles-
cents, including those with normal BMI, have a higher
prevalence of insulin resistance when compared with age
and BMI matched European adolescents [14, 15]. This
ethnic difference in insulin sensitivity was attributed to the
higher body fat percentage in South-Asian children [15].
An alternative hypothesis to explain the ethnic differences
in insulin sensitivity is vitamin D deficiency. Despite plenty
of sunlight available throughout the year, a high prevalence
of vitamin D deficiency has been reported in all age groups
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including toddlers, school children, pregnant women and
their neonates, and adult males and females residing in
rural and urban India [16]. Vitamin D deficiency has been
reported in 84–92% children in the age group of 10–18 [17].
In view of high prevalence of both, insulin resistance
and vitamin D deficiency in Asian-Indian children and
adolescents, we sought to examine the relationship between
vitamin D status and insulin resistance. We also sought to
determine if puberty affected the relationship of vitamin D
status and parameters of insulin resistance and sensitivity in
Asian-Indian children and adolescents.
2. Material andMethods
2.1. Study Design. The study was conducted as a prospective
observational study after approval from the Ethics Commit-
tee of the All India Institute of Medical Sciences (AIIMS),
New Delhi. Subjects were selected from the children and
adolescents attending the endocrinology outdoor services at
AIIMS for evaluation of obesity. Written informed consent
was obtained from parents of all subjects. Additionally,
assent was also obtained from subjects more than seven
years old. The inclusion criteria included children between
the ages of 6–17 years with obesity as per International
Obesity Taskforce (IOTF) criteria [18]. The exclusion criteria
included subjects with diagnosed diabetes mellitus or taking
metformin or any weight reducing drugs, subjects with any
known systemic illness or endocrine or metabolic disorders,
known to be associated with obesity, or subjects with
symptoms to suggest hypothalamic obesity were excluded
from the study.
2.2. Methods. Detailed history, clinical and anthropometric
examination was carried out. Blood samples were collected
in fasting state (minimum 9 hours fasting), followed by
oral glucose tolerance test (anhydrous glucose = 1.75 gm/kg
bodyweight, maximum of 75 gram, dissolved in 250mL of
water, ingested over 5 minutes) with sample collection at 60
and 120 minutes after glucose ingestion.
2.3. Anthropometric Measurements. All measurements were
made with subjects dressed in minimal light clothing but
without footwear. Height was measured with Holtain’s
stadiometer (Holtain Inc., Crymych, Pembs. UK). Weight
was measured with the same digital weighing machine. Waist
circumference was measured (nonelastic measuring tape) at
the end of normal expiration at the midpoint between the
iliac crest and the lower edge of ribs in the midaxillary line.
Hip circumference was measured at the point of maximum
circumference over the buttocks. Blood pressure (BP) was
measured in the right upper limb in sitting position with
a mercury sphygmomanometer after 5-minute rest with an
appropriate size cuff. BP was measured three times and
mean value was taken. Total body fat was measured with
dual energy X-ray absorptiometry (DXA, Hologic QDR 4500
with pediatric software, Hologic Inc., Waltham, MA, USA).
Fat mass index (FMI, fat mass in kg/height in meter2) and
fat-free mass index (FFMI, lean body mass+ BMC)/(height
in meter)2 were calculated. Bone mineral area, content
(BMC) and areal density (aBMD) at the femoral neck,
lumbar spine (L1-5), and forearm were measured, using
a Hologic QDR 4500A fan beam DXA machine. Hologic
spine phantom (Hologic spine phantom number 21373)
was scanned daily before subject evaluation. The measured
phantom bone mineral density was stable throughout the
study period at 0.915–0.945 gm/cm2. Similarly, whole body
phantom (Hologic WB number 1252) was also scanned
before subject evaluation and remained stable during study
period. The in vivo precision error for adults was 0.62% for
femoral neck aBMD, 0.65% for lumbar spine aBMD, and
0.77% for forearm aBMD. However, in view of additional
radiation exposure, the reproducibility of these scans was not
assessed among children.
2.4. Pubertal Staging. Pubertal stage was assessed by a
single endocrinologist, based on breast stage and pubic hair
development in girls [19] and genitalia development in boys
[20].
2.5. Measurement of Carotid Intima Media Thickness (CIMT).
B-mode ultrasonography was used to measure CIMT (7.5–
10MHz probe, Philips Envisor ultrasound machine) using
standard protocol [21].
2.6. Indices of Glucose and Insulin Metabolism
(a) Insulin Resistance (IR) was calculated by computer-
based model called homeostasis assessment model
(HOMA-IR) utilizing fasting blood glucose and
fasting serum insulin levels [22].
(b) The Whole Body Insulin Sensitivity Index (WBISI)
or Matsuda Index was calculated by the formula
suggested by Matsuda and DeFronzo [23].
(c) Area under Curve (AUC) was calculated for blood
glucose (0, 60, and 120 minutes) and serum insulin
(0, 60, and 120 minutes) by using trapezoidal rule.
2.7. Biochemical Analysis. Complete blood counts, liver
function tests, renal function test, serum calcium (corrected
calcium with serum albumin), phosphate, alkaline phos-
phatase, uric acid, and blood glucose were measured in
all subjects with an automated chemistry analyzer (Roche
Hitachi 912 Chemistry Analyzer, GMI Inc., USA). Gly-
cosylated hemoglobin (HbA1c) was measured in whole
blood using ion-exchange high performance liquid chro-
matography (Bio-Rad Laboratories Inc., CA, US). Serum
insulin was measured on an autoanalyzer (Roche Elecsys
2010) using electrochemiluminometric assay. Serum total
cholesterol (TC), triglyceride (TG), and HDL cholesterol
(HDL-C) levels were estimated directly with automated
analyzer, while LDL cholesterol (LDL-C) was estimated
by using the Friedewald equation [24]. Serum 25(OH)D
was measured with radioimmunoassay (RIA, DiaSorin Inc.,
Stillwater, USA). Our laboratory is registered with vitamin D
external quality assessment scheme (http://www.deqas.org/).
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Vitamin D deficiency was defined as a serum 25(OH)D
levels less than 20 ng/mL. This was further subdivided to
severe, moderate, and mild vitamin D deficiency if serum
25(OH)D levels were <5 ng/mL, 5–<10 ng/mL, and 10–
<20 ng/mL respectively [25].
3. Statistical Analysis
Statistical analysis was carried out using SPSS (SPSS version
11.5; SPSS Inc., Chicago, IL). Descriptive statistical analy-
ses were used for demographic information. Results were
expressed as mean ± standard deviation (SD) unless oth-
erwise specified. Continuous variables not showing normal
distribution were treated with appropriate log transforma-
tions before any parametric analysis. Student’s t-test was
used to determine statistical difference between subjects with
serum 25(OH)D <10 ng/mL or more. Pearson’s correlation
was used to assess association between continuous variables
and partial correlations were used to determine relation-
ship after adjusting for relevant covariates. Bonferroni’s
corrections were used for multiple comparisons. Stepwise
linear regression analysis was used with serum 25(OH)D as
dependent variable in themodel. Values for serum 25(OH)D,
serum insulin, HOMA-IR, and Matsuda ISI were not
normally distributed; therefore, they were logarithmically
transformed which yielded normal distribution.
4. Results
A total of 62 subjects participated in this cross-sectional
study from June 2008 to May 2009. The mean age of subjects
was 13.0± 3 years (35 boys; 27 girls). Assessment of pubertal
status by Tanner’s method showed 19 subjects in stage 1, 11
in stage 2, 6 in stage 3, 3 in stage 4, and 23 subjects in puberty
stage 5. Descriptive details of study subjects are given in
Table 1. No significant difference was observed between boys
and girls except higher WHR in boys than girls (0.93 ± 0.05
versus 0.89± 0.05; P = 0.013).
4.1. Serum 25-Hydroxyvitamin D (25(OH)D) Concentrations.
All study subjects were classified as vitamin D deficient
(mean ± SD 8.5 ± 4.2 ng/mL; maximum–minimum: 3.9–
19.2 ng/mL, median = 6.9 ng/mL). Severe vitamin D defi-
ciency (<5 ng/mL) was seen in 11 subjects (17.7%) while 30
subjects had serum 25(OH)D levels between 5–<10 ng/mL
(48.3%). Serum 25(OH)D equal to or more than 10 but
less than 20 ng/mL was present in 21 subjects (33.8%).
No significant difference was seen in serum 25(OH)D
concentrations between boys and girls.
Pearson correlation coefficient analyses showed signifi-
cant inverse relationship between serum 25(OH)D and total
body fat percentage (r = −0.31,P = 0.01) and serum
25(OH)D and FMI (r = −0.33,P = 0.01, Figure 1).
Partial correlation analysis showed persistence of significant
correlation between serum 25(OH)D and total body fat
percentage (r = −0.37,P = 0.005) and between serum
25(OH)D and FMI (r = −0.36,P = 0.006) even after
adjustment for age, sex, pubertal stage, and BMI. Although
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Figure 1: Correlation between Serum 25-hydroxyvitamin D con-
centration and fat mass index (FMI) in all subjects.
blood glucose and serum insulin levels showed inverse
relationship trends with serum 25(OH)D, but these were
not statistically significant (data not shown). Similarly, no
statistically significant correlation was seen between serum
25(OH)D and parameters of insulin sensitivity or resistance.
4.2. Body Fat and Insulin Resistance. FMI showed positive
correlation with HOMA-IR (r = 0.26;P = 0.04), AUC
insulin (r = 0.41;P = 0.001), AUC glucose (r = 0.31;P =
0.018), and negative correlation with WBISI (r = −0.42; r =
0.001). However, total body fat did not show any correlation
with parameters of glucose and insulin parameters.
On the basis of serum 25(OH)D, subjects were divided
into two groups, group A with serum 25(OH)D level
<10 ng/mL (n = 41) and group B with serum 25(OH)D
level ≥10 ng/mL (n = 21) (an arbitrary cutoff to compare
subjects with mild vitamin D deficiency with moderate and
severe vitamin D deficiency, 25). Descriptive details of these
two groups are provided in Table 1. No statistical significant
difference was seen in blood glucose, serum insulin, and AUC
for both, glucose and insulin between group 1 and group
2. Trends for higher insulin resistance (HOMA-IR) and
lower insulin sensitivity (WBISI) were seen in subjects with
lower serum 25(OH)D concentrations but not statistically
significant.
Total body fat percentage and FMI were significantly
higher in group 1 in comparison to group 2 (P = 0.015 and
0.007, resp.). However, no significant difference was seen in
waist and hip circumference and waist hip ratio. Similarly,
FFMI, lipid parameters, or thyroid profile were also not
different between the two groups.
4.3. Effects of Pubertal Stage. Subjects were divided into
three groups according to their pubertal status. Group 1
(prepubertal group; Tanner stage 1) had 19 subjects, group
2 (peripubertal group; Tanner stage 2, 3, and 4) had 20,
while group 3 (postpubertal group; Tanner stage 5) had 23
subjects. No significant correlation was seen between vitamin
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Table 1: Descriptive characteristics of study population.
Parameter Mean ± SD Group A: serum
25(OH)D < 10 ng/mL
Group B: serum
25(OH)D ≥ 10 ng/mL P value
Number of subjects 62 41 21
Age (in yrs) 13.0 ± 3.1 12.6 ± 3.1 13.7 ± 3.1 0.2
BMI (Kg/M2) 29.3 ± 4.8 29.3 ± 5.2 29.3 ± 3.8 0.97
Waist circumference (cms) 89.6 ± 13.3 89.4 ± 15 90 ± 11.0 0.87
Hip circumference (cms) 97.8 ± 13.03 97.4 ± 13 99 ± 14 0.71
Waist hip ratio 0.92 ± 0.06 0.91 ± 0.06 0.91 ± 0.07 0.86
Systolic BP (mm of Hg) 120 ± 12 118 ± 12 124 ± 12 0.06
Diastolic BP (mm of Hg) 79 ± 8 78 ± 7 80 ± 9 0.55
Total cholesterol (mg/dL) 154 ± 30 155 ± 29 154 ± 34 0.94
Triglyceride (mg/dL) 116 ± 47 113 ± 49 122 ± 42 0.50
HDL cholesterol (mg/dL) 40 ± 6 40 ± 6 39 ± 4 0.78
LDL cholesterol (mg/dL) 92 ± 25 92 ± 24 91 ± 28 0.86
S. T4 (μg/dL) 9.44 ± 2.1 9.50 ± 2.2 9.31 ± 2.0 0.74
S. TSH (mIU/L) 3.79 ± 2.2 3.86 ± 2.4 3.65 ± 1.9 0.74
AST (IU/L) 34 ± 20 36 ± 24 30 ± 7 0.29
ALT (IU/L) 42 ± 40 46 ± 48 35 ± 14 0.32
Bl. glucose at 0min (mg/dL) 95 ± 13 99 ± 17 93 ± 9 0.098
Bl. glucose at 60min (mg/dL) 135 ± 33 141 ± 37 124 ± 22 0.06
Bl. glucose at 120min (mg/dL) 120 ± 24 123 ± 26 114 ± 17 0.16
AUC glucose 241.7 ± 41.1 248.6 ± 45.7 231.3 ± 27.6 0.07
S. insulin at 0min (mU/L) 20 ± 16 22 ± 18 15 ± 8 0.2
S. insulin at 60min (mU/L) 120 ± 153 123 ± 118 118 ± 210 0.9
S. insulin at 120min (mU/L) 120 ± 175 128 ± 162 105 ± 200 0.6
AUC insulin 185.8 ± 230.6 190.2 ± 185.1 177.1 ± 305.8 0.8
HOMA-IR 4.75 ± 3.7 5.17 ± 4.1 3.91 ± 2.5 0.2
WBISI 4.23 ± 4.0 4.05 ± 4.1 4.59 ± 3.7 0.39
HbA1c (%) 5.4 ± 0.4 5.4 ± 0.3 5.4 ± 0.5 0.93
Total body fat (%) 40.8 ± 6.6 42 ± 6.6 38.0 ± 5.7 0.015
Fat mass index (Kg/M2) 12.0 ± 3.1 12.7 ± 3.2 10.6 ± 2.3 0.007
Fat-free mass index (Kg/M2) 17.2 ± 2.9 17.0 ± 3.1 17.5 ± 2.4 0.53
Serum 25(OH)D (ng/mL) 8.5 ± 4.2 5.9 ± 1.4 13.6 ± 3.2 —
CIMT (mm) 0.06 ± 0.01 0.06 ± 0.01 0.05 ± 0.01 0.52
BMI: Body mass index, BP: blood pressure, AST: aspartate aminotransferase, ALT: alanine aminotreasferase, AUC: area under curve, WBISI: whole body
insulin sensitivity index, CIMT: carotid intima media thickness.
D status and any other parameters including total body
fat percentage, FMI and parameters of insulin resistance
and sensitivity in the prepubertal (group 1) or peripubertal
groups (group 2). Partial correlations after adjusting for age,
sex, and BMI were also nonsignificant for both groups (data
not shown).
In postpubertal subjects (group 3, n = 23), a significant
inverse correlation was seen between serum 25(OH)D and
HOMA-IR (r = −0.41, P = 0.03, Figure 2). This association
between serum 25(OH)D andHOMA-IR persisted even after
control for age, sex, and BMI (r = −0.505, P = 0.023).
Positive trends of association between serum 25(OH)D and
WBISI were also seen, but this was not significant (r =
0.29,P = 0.17), even after adjusting for age, sex, and
BMI (r = 0.35,P = 0.13). Serum 25(OH)D showed
significant inverse correlation with total body fat percentage
(r = −0.58,P = 0.003) and FMI (r = −0.49,P =
0.016) which improved after adjusting for age sex and BMI
(r = −0.63,P = 0.002 for total body fat percentage; r =
−0.582, P = 0.007 for FMI). Serum 25(OH)D also showed
significant inverse relationship with fasting serum insulin
levels (r = −0.44,P = 0.034) which improved after adjusting
for age, sex, and BMI (r = −0.53,P = 0.016).
When prepubertal subjects (group 1) were compared
with the prepubescent subjects (group 2), no significant
difference was seen in any of the parameters including blood
glucose, serum insulin, HOMA-IR, and WBISI. Similarly,
when prepubertal subjects were compared with all other
subjects (subjects in group 2 and 3 combined), significantly
higher insulin sensitivity (WBISI, mean ± SD 6.07 ± 5.7
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Figure 2: Correlation between serum 25(OH)D concentrations and
HOMA-IR in post-pubertal subjects (group 3).
versus 3.42 ± 2.7,P < 0.01) and lower insulin resistance
(HOMA-IR, mean ± SD 3.68 ± 2.7 versus 5.22 ± 4.0,P =
0.04) were seen in prepubertal subjects.
5. Discussion
This is the first study examining the relationship between
serum 25(OH)D levels and parameters of insulin resistance
in obese Asian-Indian children. Our study confirms a
significant inverse relationship between serum 25(OH)D
levels and body fat indices as reported in other studies in
children [6, 10]. We demonstrated trends for that higher
serum 25(OH)D levels are associated with better insulin
sensitivity and less insulin resistance though this correlation
did not reach statistical significance. One of the main reasons
for the absence of significance could be the universal presence
of vitaminD deficiency (<20 ng/mL) resulting in very narrow
range of serum 25(OH)D. We also show, for the first time,
that the association between serum 25(OH)D and insulin
resistance and sensitivity is influenced by pubertal staging.
When subjects were stratified by pubertal stage, only subjects
in Tanner stage 5 exhibited a significant correlation between
serum 25(OH)D and HOMA-IR, while prepubertal subjects
did not show statistically significant correlation.
High prevalence of vitamin D deficiency has been
reported across the age range in pediatric, adolescent, and
adult in obese individuals [5, 6, 26–31]. All our study subjects
had vitamin D deficiency. This may be just reflection of very
high prevalence of vitamin D deficiency in Asian-Indians
[16, 17]. However, high prevalence of vitamin D deficiency
has been reported in obese children and adolescents from
populations where vitamin D deficiency is not that prevalent
[5, 6, 10]. Reis et al., in a study of 3577 adolescents in
the age group of 12–19 years, found significantly lower
serum 25(OH)D levels in adolescents with BMI > 95th
centile in comparison to subjects with BMI < 95th centile
(P < 0.001) [7]. It has been postulated that increased
sequestration of vitamin D in fat tissues, leading to decreased
vitamin D bioavailability, low dietary vitamin D intake due
to poor nutritional habits, and minimal sun exposure due
to sedentary indoor lifestyle are important factors associated
with high prevalence in the obese population [29, 32]. It has
also been suggested that vitamin D deficiency is a cause of
common obesity and can account for the secular trends in
the prevalence of obesity and for individual differences in its
onset and severity [33].
The inverse relationship between serum 25(OH)D and
insulin resistance in adults have been reported in most
studies, though some have failed to find this association
[3]. In comparison, reports in children and adolescents have
shown conflicting results. Delvin et al. [6], in a study of 1745
French-Canadian children, reported modest but significant
negative associations between serum 25(OH)D and HOMA-
IR. Each 10-nmol/L (4 ng/mL) increase in serum 25(OH)D
was associated with lower glycemia and HOMA-IR [6].
Reinehr et al. [8] in a study of 133 obese Caucasian
children did not find significant correlation between serum
25(OH)D levels and insulin, HOMA-IR and HOMA-B %. In
another study based on NHANES data of 3577 adolescents
from 2001–2004 showed that serum 25(OH)D levels were
inversely associated with plasma glucose concentration (P =
0.01). Lenders et al., in a study of 58 obese adolescents,
did not found any correlation between insulin indices and
serum 25(OH)D in both, adjusted and unadjusted models.
In our study, we did not find a statistically significant
association between serum 25(OH)D and parameters of
insulin sensitivity and resistance. However, trends for higher
blood glucose and serum insulin levels were seen in subjects
with low serum 25(OH)D level. Similar observation was also
seen with AUC glucose and AUC insulin. No significant
difference was seen in insulin resistance and sensitivity
between group 1 and group 2. This is in contrast to
the observations made by Ashraf et al. who reported in
51 African-American obese female adolescents [10] that
higher serum 25(OH)D concentrations were associated with
significantly higher WBISI (P = 0.018) but no difference in
HOMA-IR. The AUC for insulin was also higher in subjects
with lower serum 25(OH)D. These differences may be due
to marked difference in severity of obesity as mean BMI of
study subjects was 43.3±9.9 in study by Ashraf et al., while it
was 29.3± 9.8 kg/sqM in our study subjects. Studies in adult
population have shown that parameters of insulin sensitivity
and insulin resistance as calculated by hyperinsulinemic
euglycemic clamp study (M value) correlated better with
serum 25(OH)D levels than indirect parameters like HOMA-
IR [34]. Studies with direct measures of insulin sensitivity
like clamp studies are required to further investigate these
issues in pediatric and adolescent population.
Insulin resistance is a feature of obesity and hallmarks
normal pubertal development. The phenomenon of pubertal
insulin resistance has been well described in cross-sectional
as well as longitudinal studies [35]. A longitudinal study of
insulin resistance in American children showed that during
puberty, insulin sensitivity decreased by ∼50%, with a com-
pensatory increase in plasma insulin which is independent
of the changes in body fat [36]. These changes are thought
to be mediated by interaction of various hormones during
puberty including increased growth hormone secretion [36].
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No studies have yet reported the relationship between
serum 25(OH)D concentrations and insulin sensitivity and
resistance in pediatric and adolescent population and the
potential influence of puberty except one [37]. Lenders et al.
reported no significant association between serum 25(OH)D
and insulin indices, even after adjusting for Tanner stage
[37]. However, our study, for the first time, shows that the
relationship between serum 25(OH)D concentrations and
insulin resistance is influenced by puberty. When subjects
with all stages of puberty were analyzed, no significant
correlation was found, but when subjects in Tanner stage 5
were analyzed alone, significant inverse correlation was seen
between serum 25(OH)D concentrations and HOMA-IR
(r = −0.41,P = 0.03). This association persisted/improved
after controlling for age, sex, and BMI (r = −0.505,P =
0.023) but disappeared when subjects were controlled for
FMI (r = −0.27,P = 0.24). These differences in results may
be due to differences in study population characteristics.
Most of the evidence of an association between adiposity
and vitamin D status comes from adult studies [4, 33]. A
recently published study [38] of 382 healthy subjects aged 6–
21 years with DXA scans showed that serum 25(OH)D con-
centrations were more likely to be lower in those with greater
BMI z-scores and FM, but not FFM. When this association
was adjusted for possible covariates in the model, it became
nonsignificant. Using DXA to measure FM, Lenders et al.
[37] showed that obese adolescents with and without vitamin
D deficiency differed according to FM and FM percentage,
but not lean mass and this relation of FM percentage
to serum 25(OH)D remained significant after potential
confounding variables were adjusted for. Rajakumar et al.
showed that vitamin D deficiency was associated with higher
visceral adipose tissue in white and greater subcutaneous
adipose tissue in black American children and adolescents
[39]. In agreement with these studies, our findings indicate
that body fat indices (total body fat percentage and FMI)
are inversely correlated with serum 25(OH)D level. This
correlation persisted even after adjustment for possible
covariates like age, sex, and BMI. The differences in study
findings may be explained in part by differences in study
design and underlying sample characteristics like BMI and
variation in serum 25(OH)D concentrations.
The major strengths of our study are the use of robust
measures of insulin sensitivity and resistance based on
OGTT rather than fasting sample and all our study subjects
belonged to one ethnic group. We have used DXA for
assessment of body fat as opposed to several studies which
have used BMI as a surrogate for body fat. The limitations of
our study included, small sample size, presence of vitamin
D deficiency in all study subjects which gave us very
narrow range of serum 25(OH)D concentrations thereby
limiting comparisons. Absence of PTH measurement was
another important limitation, since it has been implicated in
pathogenesis of insulin resistance and metabolic syndrome.
Another important limitation was inability of DXA tech-
nique to differentiate between subcutaneous and visceral
adipose tissue.
In conclusion, our study demonstrates a significant
inverse relationship in obese Asian-Indian children between
body fat indices and serum 25(OH)D concentrations which
persists even after adjustment of covariates. The association
between serum 25(OH)D and parameters of insulin sensi-
tivity and resistance is influenced by puberty as a significant
association was found between these two variables in post-
pubertal subjects (Tanner stage 5) only which remained sig-
nificant even after adjustment for covariates. As association
is not equal to causation, future longitudinal research studies
are required in determining role of puberty on association
between serum 25(OH)D and insulin resistance in both,
obese as well as subjects with normal BMI.
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